Modernizing the Golden Hour: A New Era for Emergency Transport

PITTSBURGH, PA – July 16, 2026 – In the world of emergency medicine, the “golden hour” represents the critical window after a traumatic injury where prompt medical treatment has the highest chance of preventing death. Yet, within this crucial period lies a systemic vulnerability that has remained largely unaddressed for over half a century: the transport itself. Now, a Pittsburgh-based startup is poised to overhaul this weak link in the chain of survival.

HeadStrait Labs, a medical technology company founded in 2023, announced it has secured a $350,000 lead investment from the Richard King Mellon Foundation. This strategic funding has served as a catalyst, helping the company attract additional venture capital and grant support to bring its total raised to more than $680,000. The capital infusion is earmarked to push HeadStrait Labs from promising pilot programs toward manufacturing readiness, broader product development, and the establishment of key regional partnerships that could redefine patient safety during emergency transport.

A Sixty-Year Stasis in Pre-Hospital Care

Each year in the United States, an estimated 12.7 million people suffer a head or neck injury that necessitates immobilization and emergency transport. The harrowing reality is that for up to 25% of these patients, the journey to the hospital introduces a new trauma: a secondary injury caused by excessive movement. The consequences can be catastrophic, ranging from prolonged recovery and additional trauma to permanent paralysis or even death, contributing to an estimated annual healthcare burden of $102 billion.

The root of the problem is not a lack of effort from our highly trained EMS providers, but a profound lack of innovation in the tools they are given. The standard equipment for stabilizing a patient’s head and neck—rigid cervical collars, head blocks, and long spine boards—are fundamentally the same devices used in the 1960s. These legacy tools are often ill-fitting, uncomfortable, and provide no data on their effectiveness during transit. First responders have often been left to rely on what some in the field describe as “ill-fitting cervical collars, duct tape, and guesswork” to secure a patient’s spine.

“So much medical innovation is focused inside the OR or ER, but the critical window with EMS has been overlooked,” said Alyssa Theroux, co-founder of HeadStrait Labs. “We believe better tools and better data can help protect patients during one of the most vulnerable parts of their care journey.” This overlooked gap is precisely where HeadStrait Labs is focusing its engineering and medical expertise.

Engineering a Smarter Solution

At the heart of the company’s mission are two integrated products: EVAC-1, a stabilization splint, and SMARTmotion, its sensor-enabled analytics platform. Together, they represent a paradigm shift from static immobilization to dynamic, data-driven stabilization.

The EVAC-1 splint was designed to overcome the critical flaws of its predecessors. It is a universal, adjustable device that physically mimics the gold-standard technique of a responder holding a patient's head. Made from a combination of rigid HDPE, comfortable EVA foam inserts, and secure nylon straps, the splint is also designed to be affordable and disposable—a critical feature for frontline use. Its design allows for full airway access and includes ear holes, addressing issues of patient claustrophobia and communication. Early clinical validation studies have already shown that 79% of patients preferred the EVAC-1 over a standard cervical collar, a testament to its focus on patient comfort.

What truly elevates the system is the SMARTmotion technology. This removable sensor pack, which utilizes gyroscopes and accelerometers, attaches to the splint and provides real-time feedback on patient movement. Indicator lights can alert the EMS crew to a dangerous misalignment as it happens, allowing them to adjust in the moment. This transforms a routine transport from a black box of uncertainty into a transparent, data-rich patient encounter. After the event, the analytics dashboard provides physicians with a clear record of what happened before the patient arrived and gives EMS agencies invaluable data for training and protocol refinement.

The company’s work is backed by rigorous clinical research, including ongoing IRB-approved studies with UPMC, Pittsburgh’s premier healthcare provider, which are expected to yield definitive device data by mid-2026. This collaboration, along with guidance from medical advisors like Dr. Leonard Weiss, medical director for the City of Pittsburgh Department of Public Safety and EMS, grounds the technology in the practical realities of emergency medicine.

Impact Investing as a Catalyst for Regional Innovation

The investment from the Richard King Mellon Foundation is significant not just for its monetary value, but for what it represents. It is part of the Foundation’s Social-Impact Investment (SII) program, which uses its capital to invest in for-profit companies whose missions align with its philanthropic goals. Since 2021, the Foundation has invested over $32 million in 78 such companies, demonstrating a powerful model where philanthropic capital can fuel life-saving commercial ventures.

For a company like HeadStrait Labs, whose work aligns directly with the Foundation’s “Health & Well-Being” priority, this type of investment provides more than just runway; it provides validation and access to a powerful regional network. The investment mandates that the resulting social impact benefits the communities of Allegheny and Westmoreland counties, ensuring that local innovation directly serves the local population. This for-profit, for-purpose model is becoming a cornerstone of how regions like Southwestern Pennsylvania are fostering a self-sustaining ecosystem of technological and social progress.

“This investment helps us move from pilots and promising field feedback toward the manufacturing readiness, testing and partnerships needed for broader adoption,” said Mary Squire, co-founder of HeadStrait Labs. The funding will directly support the creation of partnerships with regional EMS agencies, hospitals, athletic programs, and senior living communities, embedding the technology within the local healthcare infrastructure.

From University Project to Market-Ready Lifesaver

The story of HeadStrait Labs is a testament to the power of Pittsburgh's collaborative innovation ecosystem. Co-founders Alyssa Theroux and Mary Squire, both biomedical engineers, met in Carnegie Mellon University's master's program. Their initial academic project quickly evolved into a mission-driven company after they identified the glaring innovation gap in pre-hospital care.

Their journey was not a straight line. After developing an initial high-tech prototype, they conducted over 100 customer discovery interviews with EMS providers. This crucial feedback from the front lines led them to pivot, redesigning their device into the current EVAC-1: a simpler, more scalable, and disposable model that met the real-world needs of first responders. This user-centric approach was further cultivated through participation in programs like Innovation Works' Robotics Factory Accelerate, which provided early funding and mentorship.

This deliberate, iterative process, backed by a series of local funding wins and culminating in the significant investment from the Richard King Mellon Foundation, has put HeadStrait Labs on a clear path to market. With plans for a major pre-sale in 2026 and FDA preparations underway, the company is preparing to scale its solution, aiming to eventually serve not only civilian EMS but also hospital trauma teams and military medics. For the millions of patients who rely on emergency transport each year, this transition from a 60-year-old standard of care to a modern, data-informed system cannot come soon enough.